HemoTimes AdminApr 191 minMore Hemlibra DeathsGenentech released the quarterly fatalities report for Emicizumab (Hemlibra) and there are now 34 reported deaths. This makes it the most...
HemoTimes AdminJan 222 minCure 4 The Kids Foundation Loses Federal Funding Due to MisappropriationThe Cure 4 The Kids Foundation based in Las Vegas, Nevada lost its funding due to misappropriating federal funds. Annette Logan-Parker (p...
HemoTimes AdminJan 161 minHemlibra Fatalities Now at 23!Well, like clockwork, Genentech has released the quarterly fatalities report for Hemlibra.(Emicizumab) A few weeks ago, we published a po...
HemoTimes AdminJan 81 minVirus used in gene therapies may pose cancer riskJust as gene therapy finally seems to be living up to its promise, a study has revived a lingering worry about the viral vessel that many...
HemoTimes AdminJan 21 min2019 in RetrospectWell, we are now in 2020. Last year was kind of rocky for the bleeding disorder community. There was a lot of not-so-good news that we in...
HemoTimes AdminDec 9, 20192 minDoctor Expresses Concern Over Hemlibra FatalitiesOn November 7, 2019, the New England Journal of Medicine published a letter to the Editor from Louis M. Aledort, M.D. from the Icahn Scho...
HemoTimes AdminNov 25, 20191 minJudge Rules Ex-Sanofi Employee to for Work for BioMarin Sanofi SA’s Genzyme unit cannot block a former employee from joining BioMarin Pharmaceutical Inc, where he would help launch a gene thera...
HemoTimes AdminOct 16, 20191 minHemlibra Fatalities Rise to 17Well, Genentech just released their quarterly fatalities report on Emicizumab (Hemlibra) and we are now up to 17. This is 4 more than las...
HemoTimes AdminOct 14, 20191 minTremeau Pharmaceuticals Wants To Give Hemophiliacs Heart Attacks Tremeau Pharmaceuticals, a private Massachusetts company, is developing a generic version of Vioxx as a treatment for severe joint pain i...
HemoTimes AdminOct 14, 20191 minCSL BEHRING MISPRINTS LABEL AND STILL SHIPS PRODUCTAh, there is no shortage of news these days with these pharma companies. It’s a great time to have a bleeding disorder news website. CSL ...
HemoTimes AdminOct 11, 20192 minHemoAware President & CEO Mentioned in MDedge ArticleHemoAware's President and CEO, Jesse John Francis Clark was interviewed by MDedge for an article on Genentech's translucent particle stat...
HemoTimes AdminOct 9, 20191 minNovo Nordisk and bluebird bio Enter 3-Year Gene Therapy CollaborationCambridge, Massachusetts-based bluebird bio and Bagsvaerd, Denmark-based Novo Nordisk announced they have agreed to collaborate to develo...
HemoTimes AdminOct 7, 20191 minGenentech Keeps Patients in The Dark about Particulate Matter in Emicizumab (HEMLIBRA) Today, Genentech released a statement (see below) regarding particulate matter found in Emicizumab. (HEMLIBRA) They noticed the matter ba...
HemoTimes AdminOct 7, 20191 minSobi to Partner with Sanofi on New One a Week Factor ProductSwedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) has entered into an expanded agreement with Sanofi to exercise early opt-in for the...
HemoTimes AdminSep 21, 20191 minCan Anyone Do Their Job Correctly for The Hemophilia Community?On August 1, 2019, Medvantx shipped ancillary supplies, including syringes, transfer needles, injection needles, alcohol prep pads, gauze...
HemoTimes AdminSep 16, 20191 minBayer Screws Up AgainBayer annouced a recall on two (2) lots of Kogenate FS 2000 IU vials. What these lots were supposed to contain were vials labled as Kogen...
HemoTimes AdminAug 13, 20193 minThe Hemophilia Community is Not Prepared to Handle an EmergencyAs the President and CEO of a bleeding disorder nonprofit, I need to publicly let this out. What occurred over the past couple of weeks w...
HemoTimes AdminAug 12, 20191 minBioMarin Drops Lower Dose of its Hemophilia Gene Therapy as it Eyes Submissions by Year-EndBioMarin are dropping the 4e13 dose for thier Hemophilia A gene therapy and are going for 6e13 for all. They are trying to aim for a 1 ye...
HemoTimes AdminAug 12, 20191 minM3 Global Research is a ScamHemoAware was contacted by M3 Global Research as they were interested in getting our patients to complete a survey for market research. W...
HemoTimes AdminJul 18, 20191 minHemlibra Fatalities Rise to 13Genentech has released an updated fatalities report. They have reported 13 fatalities to date. Again, they give no information regarding ...
